These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6220335)

  • 1. [Effects of 5023 SE on PaO2 at rest in elderly patients with cerebral impairment. A double-blind cross-over trial versus placebo].
    Memin Y
    Presse Med; 1983 Mar; 12(13):849-51. PubMed ID: 6220335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Demonstration of the therapeutic activity of 5023 SE on intellectual and psychomotor efficacy in elderly impaired patients. Double-blind controlled study versus placebo].
    Berthaux P; Laforestrie R
    Presse Med; 1983 Mar; 12(13):852-5. PubMed ID: 6220336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo].
    Rapisarda V; Azzaro E; Fichera G
    Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Ann Med Interne (Paris); 1990; 141 Suppl 1():31-5. PubMed ID: 2082783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
    Sebban C; Berthaux P
    Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
    Devissaguet M
    Presse Med; 1983 Mar; 12(13):823-9. PubMed ID: 6220330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.
    Li S; Long J; Ma Z; Xu Z; Li J; Zhang Z
    Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the therapeutic effect of duxil in chronic cerebral insufficiency. Analysis of 4636 patients at cerebrovascular risk].
    Mémin Y
    Rev Med Interne; 1988 Feb; 9(1):64-72. PubMed ID: 3387704
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of 5023 SE on experimental cerebral ischemia in gerbils].
    Duhault J; Roman F; Dellazuana O; Actis H
    Presse Med; 1983 Mar; 12(13):844-6. PubMed ID: 6220333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of acute and chronic cerebral ischemia in man by positron and single photon emission tomography: application to the study of duxil].
    Guez D
    Rev Med Interne; 1988 Feb; 9(1):33-9. PubMed ID: 3260395
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
    Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
    Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental models in cerebral ischemia: application to the study of duxil].
    Labrid C
    Rev Med Interne; 1988 Feb; 9(1):21-6. PubMed ID: 3291037
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the activity of duxil in the endocochlear hypoacusis of ischemic origin].
    Soubeyrand L; Bordes LR; Blondin P
    Rev Med Interne; 1988 Feb; 9(1):45-50. PubMed ID: 3387702
    [No Abstract]   [Full Text] [Related]  

  • 15. A single orally administered dose of almitrine improves pulmonary gas exchange during exercise in patients with chronic air-flow obstruction.
    Escourrou P; Simonneau G; Ansquer JC; Duroux P; Lockhart A
    Am Rev Respir Dis; 1986 Apr; 133(4):562-7. PubMed ID: 3083741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C; Howard P; Ansquer JC
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo].
    Paramelle B; Joubert C; Dain MP
    Presse Med; 1984 Oct; 13(34):2094-8. PubMed ID: 6149538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
    Eur Neurol; 1995; 35 Suppl 1():1-46. PubMed ID: 8529722
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
    Bury T; Jeannot JP; Ansquer JC; Radermecker M
    Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Almitrine effect on nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease (COPD).
    Daskalopoulou E; Patakas D; Tsara V; Kazis A; Maniki E; Zoglopitis F
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():185s-190s. PubMed ID: 3690030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.